Increased intratumoral IL-22-producing CD4+ T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival

Cancer Immunology, Immunotherapy

Volumn 61, Issue 11, 2012, Pages 1965-1975

  Zhuang, Yuan ^a   Peng, Liu Sheng ^a   Zhao, Yong Liang ^a   Shi, Yun ^a   Mao, Xu Hu ^a   Guo, Gang ^a   Chen, Weisan ^b   Liu, Xiao Fei ^a   Zhang, Jin Yu ^a   Liu, Tao ^a   Luo, Ping ^a   Yu, Pei Wu ^a   Zou, Quan Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b AUSTIN HOSPITAL   (Australia)

Author keywords

Gastric cancer; IL 22+CD4+ T cells; Th22 cells; Tumor progression; Tumor survival

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TH22 CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD14; CD4-POSITIVE T-LYMPHOCYTES; CELL POLARITY; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE PROGRESSION; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKIN-6; INTERLEUKINS; MALE; MIDDLE AGED; MONOCYTES; STOMACH NEOPLASMS;

EID: 84871018340     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1241-5     Document Type: Article

References (28)

1. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ (2009) Gastric cancer. Lancet 374:477-490
2. Lee HE, Chae SW, Lee YJ, Kim MA, Lee HS, Lee BL, Kim WH (2008) Prognostic implications of type and density of tumour-inWltrating lymphocytes in gastric cancer. Br J Cancer 99:1704-1711
3. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT (2005) Interleukin 17-producing CD4 + eVector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-1132
4. Trifari S, Spits H (2010) IL-22-producing CD4 + T cells: middlemen between the immune system and its environment. Eur J Immunol 40:2369-2371
5. Nograles KE, Zaba LC, Shemer A et al (2009) IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol 123(e2):1244-1252
6. Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, Krueger JG (2009) Human langerhans cells induce distinct IL-22-producing CD4 + T cells lacking IL-17 production. Proc Natl Acad Sci USA 106:21795-21800
7. Eyerich S, Eyerich K, Pennino D et al (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119:3573-3585
8. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H (2009) IdentiWcation of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10:864-871
9. Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A (2010) Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 130:1373-1383
10. Zhang L, Li JM, Liu XG et al (2011) Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J Clin Immunol 31:606-614
11. Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immuno editing: integrating immunity's roles in cancer suppression and promotion. Science 331:1565-1570
12. Albini A, Sporn MB (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7:139-147
13. Moser B, Loetscher P (2001) Lymphocyte traYc control by chemokines. Nat Immunol 2:123-128
14. Curiel TJ, Wei S, Dong H et al (2003) Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 9:562-567
15. Zhou G, Drake CG, Levitsky HI (2006) AmpliWcation of tumorspeciWc regulatory T cells following therapeutic cancer vaccines. Blood 107:628-636
16. Lewis CE, Pollard JW (2006) Distinct role of macrophages in diVerent tumor microenvironments. Cancer Res 66:605-612
17. Kuang DM, Peng C, Zhao Q, Wu Y, Zhu LY, Wang J, Yin XY, Li L, Zheng L (2010) Tumor-Activated monocytes promote expansion of IL-17-producing CD8 + T cells in hepatocellular carcinoma patients. J Immunol 185:1544-1549
18. Dumoutier L, Louahed J, Renauld JC (2000) Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 164:1814-1819
19. Sakamoto T, Saito H, Tatebe S, Tsujitani S, Ozaki M, Ito H, Ikeguchi M (2006) Interleukin-10 expression signiWcantly correlates with minor CD8 + T-cell inWltration and high microvessel density in patients with gastric cancer. Int J Cancer 118:1909-1914
20. Yan S, Zhang H, Xie Y, Sheng W, Xiang J, Ye Z, Chen W, Yang J (2010) Recombinant human interleukin-24 suppresses gastric carcinoma cell growth in vitro and in vivo. Cancer Invest 28:85-93
21. SzaXarska A, Szczepanik A, Siedlar M, Czupryna A, Sierzega M, Popiela T, Zembala M (2009) Preoperative plasma level of IL-10 but not of proinXammatory cytokines is an independent prognostic factor in patients with gastric cancer. Anticancer Res 29:5005-5012
22. Gurney AL (2004) IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int Immunopharmacol 4:669-677
23. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271-2279
24. Kreymborg K, Etzensperger R, Dumoutier L, Haak S, Rebollo A, Buch T, Heppner FL, Renauld JC, Becher B (2007) IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J Immunol 179:8098-8104
25. Wakita D, Chamoto K, Ohkuri T, Narita Y, Ashino S, Sumida K, Nishikawa H, Shiku H, Togashi Y, Kitamura H, Nishimura T (2009) IFN-gamma-dependent type 1 immunity is crucial for immunosurveillance against squamous cell carcinoma in a novel mouse carcinogenesis model. Carcinogenesis 30:1408-1415
26. Prabhala RH, Pelluru D, Fulciniti M, Prabhala HK, Nanjappa P, Song W, Pai C, Amin S, Tai YT, Richardson PG, Ghobrial IM, Treon SP, Daley JF, Anderson KC, Kutok JL, Munshi NC (2010) Elevated IL-17 produced by TH17 cells promotes myeloma cellgrowth and inhibits immune function in multiple myeloma. Blood 115:5385-5392
27. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W (2008) Interleukin-22 mediates early host defense against attaching and eVacing bacterial pathogens. Nat Med 14:282-289
28. Xie MH, Aggarwal S, Ho WH, Foster J, Zhang Z, Stinson J, Wood WI, Goddard AD, Gurney AL (2000) Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 275:31335-31339